These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The extent of androgen receptor and HER2 expression allows for targeted therapy in most cases of salivary duct carcinoma: analysis of clinical and histopathological data in a tertiary care center. Mayer M, Wolber P, Prinz J, Jansen L, Esser J, Shabli S, Quaas A, Klußmann JP, Sharma SJ, Nachtsheim L, Arolt C. Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3779-3789. PubMed ID: 38587651 [Abstract] [Full Text] [Related]
5. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands. Boon E, Bel M, van Boxtel W, van der Graaf WTA, van Es RJJ, Eerenstein SEJ, Baatenburg de Jong RJ, van den Brekel MWM, van der Velden LA, Witjes MJH, Hoeben A, Willems SM, Bloemena E, Smit LA, Oosting SF, PALGA Group, Jonker MA, Flucke UE, van Herpen CML. Int J Cancer; 2018 Aug 15; 143(4):758-766. PubMed ID: 29492965 [Abstract] [Full Text] [Related]
6. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis. Haderlein M, Scherl C, Semrau S, Lettmaier S, Hecht M, Erber R, Iro H, Fietkau R, Agaimy A. Strahlenther Onkol; 2017 Nov 15; 193(11):961-970. PubMed ID: 28828496 [Abstract] [Full Text] [Related]
7. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact. Locati LD, Perrone F, Cortelazzi B, Bergamini C, Bossi P, Civelli E, Morosi C, Lo Vullo S, Imbimbo M, Quattrone P, Dagrada GP, Granata R, Resteghini C, Mirabile A, Alfieri S, Orlandi E, Mariani L, Saibene G, Pilotti S, Licitra L. Eur J Cancer; 2016 Dec 15; 69():158-165. PubMed ID: 27821319 [Abstract] [Full Text] [Related]
8. Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations. Wang K, Russell JS, McDermott JD, Elvin JA, Khaira D, Johnson A, Jennings TA, Ali SM, Murray M, Marshall C, Oldham DS, Washburn D, Wong SJ, Chmielecki J, Yelensky R, Lipson D, Miller VA, Stephens PJ, Serracino HS, Ross JS, Bowles DW. Clin Cancer Res; 2016 Dec 15; 22(24):6061-6068. PubMed ID: 27334835 [Abstract] [Full Text] [Related]
12. Prognostic factors and outcome analysis of salivary duct carcinoma. Han MW, Roh JL, Choi SH, Nam SY, Lee HJ, Cho KJ, Lee SW, Kim SY. Auris Nasus Larynx; 2015 Dec 15; 42(6):472-7. PubMed ID: 26028371 [Abstract] [Full Text] [Related]